CHINA PHARMA HOLDINGS, INC. Operating Lease, Liability, Noncurrent
CHINA PHARMA HOLDINGS, INC. (CPHI) had Operating Lease, Liability, Noncurrent of $75.29 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-14
- 2026-06-30: Operating Lease, Liability, Noncurrent $75.29K.
- 2026-03-31: Operating Lease, Liability, Noncurrent $92.29K.
- 2025-12-31: Operating Lease, Liability, Noncurrent $111.55K.
- 2025-09-30: Operating Lease, Liability, Noncurrent $128.26K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $75.29K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $92.29K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $111.55K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $128.26K 10-Q · filed 2025-11-12 |
| 2023-12-31 | $39.91K 10-K · filed 2025-03-31 |
| 2023-09-30 | $58.79K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $77.55K 10-Q · filed 2023-08-14 |
| 2022-03-31 | $22.32K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $44.18K 10-K · filed 2023-03-30 |
| 2021-09-30 | $64.77K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $86.19K 10-Q · filed 2021-08-13 |
| 2020-03-31 | $24.80K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $48.70K 10-K · filed 2021-03-26 |
| 2019-09-30 | $70.95K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $96.30K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $122.23K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |